"Post-Sex Doxy-PEP: A Promising Defense Against STDs"

Scientists have discovered that the antibiotic doxycycline, when taken as a post-exposure prophylaxis (PEP) within hours after sex, can significantly reduce the risk of contracting common bacterial sexually transmitted infections (STIs) such as chlamydia, gonorrhea, and syphilis. Known as doxy-PEP, this prevention tool has shown promising results in clinical trials, leading the Centers for Disease Control and Prevention (CDC) to plan the release of guidance for doctors and public health departments on how to offer it. While concerns about antibiotic resistance exist, experts believe that the potential of doxy-PEP to curb rising STI rates cannot be ignored.